← Back to Screener
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Price$57.35
Favorite Metrics
Price vs S&P 500 (26W)22.18%
Price vs S&P 500 (4W)0.43%
Market Capitalization$115.83B
P/E Ratio (Annual)14.98x
Indicated Dividend Yield (Annual)3.26%
All Metrics
P/CF (Annual)11.06x
Book Value / Share (Quarterly)$5.44
P/TBV (Annual)325.88x
Indicated Dividend (Annual)$85.22
Revenue Growth (3Y)3.66%
Cash Flow / Share (Quarterly)$1.58
Payout Ratio (TTM)44.86%
Price vs S&P 500 (YTD)14.27%
Gross Margin (TTM)72.67%
Net Profit Margin (TTM)17.50%
EPS (TTM)$1.88
10-Day Avg Trading Volume5.25M
EPS Excl Extra (TTM)$1.88
Revenue Growth (5Y)6.05%
EPS (Annual)$1.88
Dividend / Share (Annual)$0.84
ROI (Annual)16.76%
Gross Margin (Annual)73.05%
Net Profit Margin (5Y Avg)22.14%
Cash / Share (Quarterly)$1.13
P/E Basic Excl Extra (TTM)14.98x
Revenue Growth QoQ (YoY)6.17%
EPS Growth (5Y)-0.54%
P/E Normalized (Annual)14.98x
ROA (Last FY)9.35%
Revenue Growth TTM (YoY)4.11%
EBITD / Share (TTM)$2.81
ROE (5Y Avg)52.18%
Operating Margin (TTM)24.28%
Cash Flow / Share (Annual)$1.58
P/B Ratio5.23x
P/B Ratio (Quarterly)4.51x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.06x
Net Interest Coverage (TTM)11.98x
ROA (TTM)9.43%
EPS Growth QoQ (YoY)56.43%
EV / EBITDA (TTM)11.72x
EPS Incl Extra (Annual)$1.88
Current Ratio (Annual)0.82x
Quick Ratio (Quarterly)0.54x
3-Month Avg Trading Volume5.37M
52-Week Price Return57.42%
EV / Free Cash Flow (Annual)21.02x
P/E Incl Extra (TTM)14.98x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$2.08
P/S Ratio (Annual)2.62x
Asset Turnover (Annual)0.53x
52-Week High$2282.00
Operating Margin (5Y Avg)19.76%
EPS Excl Extra (Annual)$1.88
CapEx CAGR (5Y)5.92%
Tangible BV CAGR (5Y)-48.07%
26-Week Price Return30.93%
Quick Ratio (Annual)0.52x
13-Week Price Return18.03%
Total Debt / Equity (Annual)1.08x
Current Ratio (Quarterly)0.82x
Enterprise Value$135,207.898
Revenue / Share Growth (5Y)5.60%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)2.08%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.52x
Pretax Margin (Annual)22.66%
Cash / Share (Annual)$1.05
3-Month Return Std Dev27.75%
Gross Margin (5Y Avg)71.26%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)3.52%
EBITDA Interim CAGR (5Y)8.48%
ROE (Last FY)34.90%
Net Interest Coverage (Annual)8.10x
EPS Basic Excl Extra (Annual)$1.88
P/FCF (TTM)18.00x
Receivables Turnover (TTM)4.57x
EV / Free Cash Flow (TTM)21.02x
Total Debt / Equity (Quarterly)1.08x
EPS Incl Extra (TTM)$1.88
Receivables Turnover (Annual)5.68x
ROI (TTM)17.23%
Dividend Growth Rate (5Y)-8.93%
P/S Ratio (TTM)2.62x
Pretax Margin (5Y Avg)17.50%
Revenue / Share (Annual)$10.73
Tangible BV / Share (Annual)$0.06
Forward P/E11.96x
Free OCF CAGR (5Y)-5.17%
Price vs S&P 500 (52W)22.32%
P/E Ratio (TTM)14.98x
EPS Growth TTM (YoY)122.79%
Year-to-Date Return17.51%
5-Day Price Return-2.10%
EPS Normalized (Annual)$1.88
ROA (5Y Avg)10.49%
Net Profit Margin (Annual)17.50%
Month-to-Date Return3.88%
Cash Flow / Share (TTM)$2.71
EBITD / Share (Annual)$2.68
EPS Growth (3Y)-27.62%
Operating Margin (Annual)24.28%
LT Debt / Equity (Annual)0.86x
P/CF (TTM)11.06x
ROI (5Y Avg)19.88%
P/E Excl Extra (TTM)14.98x
LT Debt / Equity (Quarterly)0.90x
EPS Basic Excl Extra (TTM)$1.88
P/TBV (Quarterly)17.94x
Payout Ratio (Annual)44.86%
P/B Ratio (Annual)4.51x
Dividend / Share (TTM)$0.84
Inventory Turnover (TTM)1.54x
Pretax Margin (TTM)22.66%
Book Value / Share (Annual)$5.44
Price vs S&P 500 (13W)15.16%
Net Margin Growth (5Y)-5.81%
Dividend Yield (TTM)2.99%
Beta1.13x
P/FCF (Annual)18.00x
Revenue / Share (TTM)$10.83
ROE (TTM)37.19%
52-Week Low$1315.00
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 2.62x | 4.11% | 72.67% | -0.54% | $57.35 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
A leading global pharmaceutical company with a diversified therapeutic portfolio spanning respiratory, vaccines, antivirals, and specialty care. The company is expanding its presence in high-growth areas including oncology and immunology. Strategic partnerships and joint ventures, particularly in HIV treatment, strengthen its market position across key segments.